TEAM (Thiotepa, Etoposide, Cytosar, Melphalan )
Showing 1 - 25 of 6,545
Neuroblastoma Trial in Minneapolis (Thiotepa, Cyclophosphamide, Melphalan)
Recruiting
- Neuroblastoma
- Thiotepa
- +6 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Nov 2, 2022
Non-Hodgkin Lymphoma, Hodgkin Lymphoma Trial in Minneapolis (drug, procedure, biological, radiation)
Recruiting
- Non-Hodgkin Lymphoma
- Hodgkin Lymphoma
- Etoposide
- +7 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Jan 25, 2023
Ewing's Family Tumors, Renal Tumors, Hepatoblastoma Trial in Minneapolis (drug, biological, radiation, procedure)
Recruiting
- Ewing's Family Tumors
- +11 more
- Ifosfamide
- +13 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Apr 11, 2022
Autoimmune Disease, Neurologic Autoimmune Disease, Autologous Transplant Autoimmune Trial in Denver, Seattle (biological,
Recruiting
- Autoimmune Disease
- +18 more
- Anti-Thymocyte Globulin
- +9 more
-
Denver, Colorado
- +2 more
Feb 1, 2023
Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6
Withdrawn
- Recurrent Diffuse Large B-Cell Lymphoma
- +9 more
- Autologous Hematopoietic Stem Cell Transplantation
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 11, 2023
Anaplastic Ependymoma, Atypical Teratoid/Rhabdoid Tumor, CNS Germ Cell Tumor Trial in Houston (drug, procedure, biological)
Recruiting
- Anaplastic Ependymoma
- +14 more
- Etoposide
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Aug 17, 2022
Recurrent Adult Hodgkin Lymphoma Trial in Duarte (biological, drug, other, procedure)
Active, not recruiting
- Recurrent Adult Hodgkin Lymphoma
- basiliximab
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Diffuse Large B Cell Lymphoma Trial in Saint Louis (Blinatumomab, Autologous stem cell transplant, Carmustine)
Active, not recruiting
- Diffuse Large B Cell Lymphoma
- Blinatumomab
- +6 more
-
Saint Louis, MissouriWashington University School of Medicine
May 4, 2022
Crohn's Disease Trial in Pittsburgh (autologous CD34-selected peripheral blood stem cells transplant, Alemtuzumab, ATG)
Recruiting
- Crohn's Disease
- autologous CD34-selected peripheral blood stem cells transplant
- +8 more
-
Pittsburgh, Pennsylvania
- +1 more
Feb 9, 2022
TEAM Conditioning in Patients With Lymphoma (TEAM)
Completed
- Lymphoma
-
Paris, FranceMohamad Mohty
May 19, 2020
Desmoplastic Small Round Cell Tumor, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Desmoplastic Small
Recruiting
- Desmoplastic Small Round Cell Tumor
- +11 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Jun 26, 2022
Hematopoietic Cell Transplantation Recipient, Recurrent DLBCL, Recurrent Grade 1 Follicular Lymphoma Trial in Columbus
Active, not recruiting
- Hematopoietic Cell Transplantation Recipient
- +11 more
- Carmustine
- +5 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 29, 2021
Ganglioneuroblastoma, High Risk Neuroblastoma Trial in Australia, New Zealand, United States (procedure, drug, biological,
Active, not recruiting
- Ganglioneuroblastoma
- High Risk Neuroblastoma
- Autologous Hematopoietic Stem Cell Transplantation
- +14 more
-
Los Angeles, California
- +9 more
Sep 1, 2022
Diffuse Large Cell Lymphoma, Lymphoma Trial in Houston (Zevalin, Carmustine, Etoposide)
Completed
- Diffuse Large Cell Lymphoma
- Lymphoma
- Zevalin
- +6 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 12, 2021
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Buffalo (biological, drug, radiation)
Completed
- Chronic Myeloproliferative Disorders
- +7 more
- anti-thymocyte globulin
- +8 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 19, 2021
HIV Infection, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Plasmablastic Lymphoma Trial in United States (procedure, drug,
Recruiting
- HIV Infection
- +10 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
La Jolla, California
- +3 more
Dec 7, 2022
Mantle Cell Lymphoma, Recurrent DLBCL, Recurrent Follicular Lymphoma Trial in Houston (procedure, drug, biological)
Completed
- Mantle Cell Lymphoma
- +6 more
- Autologous Hematopoietic Stem Cell Transplantation
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Jan 18, 2022
Multiple Myeloma Trial in Atlanta (BeEAM)
Completed
- Multiple Myeloma
-
Atlanta, GeorgiaBlood and Marrow Transplant Group of Georgia
Oct 19, 2022
Retinoblastoma Trial in France (Melphalan or Melphalan + Topotecan, etoposide, carboplatin and vincristine, Carboplatin
Recruiting
- Retinoblastoma
- Melphalan or Melphalan + Topotecan
- +6 more
-
Saint-Denis, La RĂ©union, France
- +27 more
Nov 24, 2022
High-Risk Neuroblastoma Trial in Worldwide (Vincristine, Carboplatin, Etoposide)
Recruiting
- High-Risk Neuroblastoma
- Vincristine
- +13 more
-
Villejuif, Val De Marne, France
- +15 more
Sep 17, 2021
Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Duarte (Basiliximab, Carmustine, Cytarabine)
Recruiting
- Recurrent Hodgkin Lymphoma
- Refractory Hodgkin Lymphoma
- Basiliximab
- +6 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 16, 2022
Lymphoma, Leukemia Trial in Houston (drug, other, radiation, procedure)
Lymphoma, B-cell Lymphoma Trial in Houston (Leukapheresis, Stem Cell Transplant, CD19-specific T Cell Infusion)
Completed
- Lymphoma
- B-cell Lymphoma
- Leukapheresis
- +7 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 27, 2020
Lymphoma, HIV Trial in United States (Autologous transplant, BCNU, Etoposide)
Completed
- Lymphoma
- HIV
- Autologous transplant
- +4 more
-
Duarte, California
- +15 more
Dec 6, 2022